Hematology

New Method Rapidly Monitors Sickle Cell Disease
Sickle cell disease (SCD) is a hereditary disorder that affects red blood cells, distorting their natural disc shape into a crescent moon or "sickle" shape. Normal red blood cells move freely through small vessels throughout the body to deliver oxygen. With sickle cell disease, the misshapen red blood cells become hard and sticky, making it difficult for them to move through blood vessels. More...26 Jun 2019

Rapid Tests Assessed for Chronic Chagas Disease
Chagas disease (CD) is a parasitic disease that can affect seriously the health status of affected individuals. People with CD, mainly living in remote areas of Latin America, often face major barriers to the disease recognition, diagnosis and treatment. In the U.S., there are estimated to be at least 300,000 cases of chronic Chagas disease among people originally from countries of Latin America where Chagas disease is endemic. More...24 Jun 2019

Automated Hematology Analyzer Assessed for Malaria Diagnosis
Malaria remains a major cause of morbidity and mortality around the world. Sub-Saharan Africa is most affected with Plasmodium falciparum accounting for 99% of estimated cases. Timely and accurate diagnosis of malaria is essential for disease management and control. More...11 Jun 2019


Airway Microbiome Altered in Severe Asthma Linked to Neutrophils
Patients with mild-to-moderate asthma can experience difficulty breathing and it is especially difficult for those with Severe Asthma where symptoms can be life threatening. In either case, patients cannot participate in daily activities if their disease is uncontrolled. More...06 Jun 2019

Neutrophil-Lymphocyte Ratio Proves Possible Biomarker for ED
Erectile dysfunction is described as the impotency to obtain or sustain an erection sufficiently in order to enable convincing sexual intercourse. Erectile dysfunction (ED) is estimated to affect about 75% of men over the age of 75 and 20% of men over the age of 20. More...30 May 2019

Stem Cell Transplantation Increases Risk of Infection-Related Mortality
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapeutic modality for various malignant and nonmalignant hematological conditions. The best results of allogeneic HSCT were obtained when the stem cells from a human leukocyte antigen (HLA)-matched sibling were used, such a donor can only be found for approximately 30% of patients. More...29 May 2019
In Other News
Enzyme May Indicate Predisposition to Cardiovascular Disease
Lower HbA1c Levels Seen in Diabetic Liver Disease Patients
Sickle Cell Disease Screening Helps Save Lives of Migrants
Multiple Myeloma Sequences Reveal Prognostic Immunoglobulin Translocation
Protein Atlas Accelerates Personalized Medicine in Leukemia Patients
Early Sepsis Detection Test Approved for U.S. Marketing
High-Res Genotyping Improves Survival for Stem Cell Transplantation
Different Clinical Hematology Lab Configurations Compared
POC Hemometer Compared with Hematology Analyzer
Immune Signature Drives Leukemia Relapse after Transplantation
Biomarker Predicts Factor VIII Response in Hemophilia A
Genomic Alterations and Expression Profiles Diagnose AEL
CRYOcheck Factor VIII Inhibitor Kit Cleared for Distribution
Adverse Drug Response Risk Gene Identified for IBD
Infections Identified in Pediatric Sickle Cell Disease
Significant Hemolysis Not Required for Thrombosis in PNH
Immunohistochemical Stain Facilitates cHL Diagnosis
Clinical ddPCR Diagnostic Test System Gets FDA Clearance
Circulating Plasma DNA Potentially Identifies Incipient Tumors
Peripheral Blood Flow Cytometry Classifies Pediatric Acute Leukemia
Leukemia Prematurely Ages Bone Marrow Cells
Hypersegmented Neutrophils Associated with Reduced Lung Function
Assays Detect Inherited Blood Disorders Associated with Malaria
The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.








